14/11/2025
Until the Government take more decisive action, the onus on receiving safe treatments is in the hands of the client.
The MHRA’s Criminal Enforcement Unit has begun a series of investigations into the sale and use of unlicensed botulinum toxin products. Between 4 June and 6 August 2025, 41 confirmed cases of botulism, a rare but life-threatening condition causing paralysis, were reported in England.
Investigations show that some individuals are obtaining unlicensed products from illegal suppliers and administering injections in unsafe, informal environments such as bedrooms, kitchens, and mobile beauty settings or with visiting practitioners. Social media adverts offering “quick, cheap results” with “qualified practitioners” have been used to lure in clients.
Since May 2023, the MHRA has seized over 4,700 vials of unlicensed botulinum toxin. Nearly all of these products were sold under brand names such as Botulax, reNTox, Innotox, and Toxpia, none of which are authorised for sale in the UK.
Ensure you are receiving genuine toxin from a qualified, registered and insured medical prescribing practitioner .
